The present invention refers to a new monoclonal antibody or fragment thereof, called 14F5F6, which specifically recognizes herpes simplex virus (HSV), in its two types, herpes simplex virus type 1 and herpes simplex virus type 2 (HSV-1 and HSV-2). Preferably, the antibody of the invention is useful for the development of methods for the diagnosis of herpes simplex virus infection, as well as for the production of pharmaceutical compositions intended for the treatment, protection and/or prophylaxis of infection specifically caused by HSV-1 and HSV-2.

Generally, the present disclosure is directed to an antibody detection lateral flow assay that is specific to antibodies binding a portion of the gG protein expressed by HSV type 1 and/or type 2. The assay can be based on visual labels and interpreted without the use of a reader to provide for quick and easy detection. Multiple colored labels can be used for evaluation, and these colored labels can be covalently attached to the portion of the gG protein and the resulting modified gG-label complex applied to a substrate (e.g., backing card) for use in a binding assay.

Disclosed herein are high transducing replication defective herpes simplex virus (HSV) vectors, and methods of using the same.

Provided herein are methods of performing multiplex detection of ligand binding kinetics. In some embodiments, the methods include contacting ligands with an array of nucleic acid barcoded oscillators disposed on a first surface of a substrate that comprises an electrically conductive coating, applying an AC electric field to the substrate sufficient to induce the nucleic acid barcoded oscillators to oscillate proximal to the first surface of the substrate, and detecting changes in oscillation amplitudes of the nucleic acid barcoded oscillators over a duration to produce sets of ligand binding data. In some embodiments, the methods also include contacting barcode decoding nucleic acids with the array of nucleic acid barcoded oscillators applying an AC electric field to the substrate sufficient to induce the nucleic acid barcoded oscillators to oscillate proximal to the first surface of the substrate, and detecting changes in oscillation amplitudes of the nucleic acid barcoded oscillators over a duration to produce sets of barcode decoding data.

System and method for remote self-collection of a blood sample for assessment at a lab to detect presence of specific sexually transmitted infections (STIs). An at-home collection kit may include an ability to detect chlamydia (CT), gonorrhea (GC), bacterial vaginosis (BV), candida vaginitis (CV) and Trichomonas vaginalis (TV), HSV-2, syphilis, HIV, HBsAg, an HCV. The screening of samples for the presence of antigens and/or antibodies to infectious agents is a primary laboratory tool for the diagnosis of infections of the above viruses and bacterium. Distributing a specimen collection kit containing dried blood spot (DBS) cards can eliminate the hurdles of visiting clinics or hospitals and reduce stigma. DBS samples collected on filter paper, such as GE Whatman 903 protein saver cards, offer several advantages over on-site phlebotomist collection. The DBS cards and collection devices are especially useful for individuals who live in remote areas where healthcare resources may be limited.